Modafen Grip

Quick links to important sections

Modafen Grip

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Modafen Grip

Quick Facts

Feature Details
Classification Dual-Action NSAID and Decongestant
Active Ingredients Ibuprofen and Phenylephrine HCl
Typical Dosage 200 mg / 5 mg per film-coated tablet
Status Over-the-Counter (OTC) in most markets

Modafen Grip is a widely recognized brand-name pharmaceutical product designed for the temporary relief of symptoms associated with the common cold and influenza. Marketed typically as an over-the-counter (OTC) remedy, its primary purpose is to address the dual discomforts of pain/fever and nasal congestion.

Composition and Targeted Action

The formulation relies on a combination of two active ingredients, each targeting distinct cold and flu symptoms:

  1. Ibuprofen: This compound belongs to the class of non-steroidal anti-inflammatory drugs (NSAIDs) and serves as an analgesic (pain reliever) and antipyretic (fever reducer). Ibuprofen acts to manage inflammation, headache, and body aches. Its inclusion aims to mitigate the general malaise associated with systemic infection.
  2. Phenylephrine Hydrochloride (HCl): This component functions as a decongestant. It works by causing the blood vessels in the nasal passages to narrow, a mechanism that reduces swelling and excess mucus production. This action provides temporary relief for sinus pressure and nasal stuffiness, facilitating easier breathing.

Differentiating Features

Modafen Grip is typically formulated as an oral film-coated tablet, offering the convenience of a single product to manage both pain/fever and decongestion. This combination provides a more comprehensive symptomatic approach compared to using single-ingredient medications separately. It is generally positioned for use by adults and adolescents aged 12 years and older during the short-term course of a cold or flu, providing multi-symptom relief without the inclusion of sedating antihistamines often found in other nighttime cold preparations.

What side effects are possible with Modafen Grip?

Possible side effects and safety information

The safety profile for this combination is formally documented in regulatory labeling, classifying adverse reactions according to the body system affected and the frequency of occurrence. Common side effects reported in official documents include mild gastrointestinal discomforts, such as heartburn, stomach pain, nausea, and vomiting. Nervous system effects, such as dizziness, nervousness, and sleep problems (insomnia), are also classified as common.


Serious Adverse Reactions and Safety Constraints

Regulatory warnings highlight the risk of serious adverse reactions associated primarily with the ibuprofen component, which include an increased risk of life-threatening cardiovascular thrombotic events (heart attack and stroke). Serious gastrointestinal events, such as severe stomach bleeding, ulceration, and perforation, are also mandated warnings in labeling. These risks are officially stated to be higher if the medication is used at higher doses or for longer durations than directed.

Regulatory constraints specify that the product must not be used concurrently with any other non-steroidal anti-inflammatory drugs (NSAIDs) or products containing other nasal decongestants, including phenylephrine. Furthermore, the label defines specific safety considerations for patient groups: older adults (age 60 or older) have an increased chance of severe stomach bleeding, and use is generally avoided from 20 weeks or later in pregnancy.

Overdose and Emergency Response

Overdose and when to seek help

Overdose involving this combination product is documented in regulatory labeling with a specific profile of clinical manifestations and required emergency actions.


Documented Overdose Presentations

Initial symptoms documented in official sources include gastrointestinal disturbances such as nausea, vomiting, and abdominal pain, alongside CNS effects like tinnitus (ringing in the ears), headache, confusion, drowsiness, and lethargy. The systems most affected are the Cardiovascular system, potentially presenting with severe hypertension and bradycardia; the Central Nervous System, which risks coma and seizures; and the Renal system. Severe outcomes explicitly documented include acute renal failure and gastrointestinal bleeding. Official labeling notes that children may exhibit unique signs such as apnea, while elderly patients are cited as being at higher risk for certain side effects.


Regulatory Mandates for Emergency Action

Regulatory authorities mandate that individuals seek medical help or contact a Poison Control Center right away for any suspected overdose, regardless of initial symptoms. Immediate notification of emergency services is required if the person has collapsed, experienced a seizure, or has trouble breathing. Management is primarily symptomatic and supportive treatment; no specific antidote is known for the ibuprofen component. Monitoring requirements may include observation of vital signs, ECG, and laboratory checks for renal function.

Therapeutic Uses of Modafen Grip

What Modafen Grip Treats: Main Uses and Benefits

Modafen Grip is applied across therapeutic domains where additional symptomatic support is needed during episodes of acute viral illness, such as the common cold and influenza. The specific combination may be part of symptomatic management for the characteristic cluster of symptoms that may become disruptive during flare-ups.

Therapeutic Scope

This formulation is relevant for easing symptoms related to systemic imbalance and organ-specific functional stress. It provides supportive relief for elevated temperature and widespread muscle pain, and is applied in addressing significant nasal stuffiness and associated sinus pressure. The medication is commonly used to help manage the simultaneous presence of three primary symptom manifestations: fever, generalized body aches and pain, and nasal congestion.

Modafen Grip may help maintain a sense of stability when multiple symptoms are more noticeable, contributing to easing the overall symptom load.


Quick Fact: Supportive Relief for Pain, Fever, and Nasal Congestion

Regulatory References

  1. U.S. Food and Drug Administration (FDA) label for ibuprofen and phenylephrine combination

Eligibility and Restrictions for Use

Modafen Grip's eligibility is strictly defined by regulatory labeling, which identifies approved populations, absolute exclusions, and conditions requiring professional oversight.

Eligibility Scope

Classification Eligible Population Excluded Population
Age Groups Adults and children 12 years of age and over Children under 12 years of age
Reproductive Status Must consult a health professional (Pregnancy/Lactation) Contraindicated at 20 weeks of pregnancy and later

Formal Contraindications (Must Not Use)

The medicine is contraindicated and must not be used by patients who fall into the following regulatory-defined categories:

  • Patients with a known hypersensitivity or severe allergic reaction to Ibuprofen, Phenylephrine, Aspirin, or any other NSAID.
  • Patients who are currently taking or have stopped taking a Monoamine Oxidase Inhibitor (MAOI) within the last 14 days.
  • Patients right before or after heart bypass surgery (CABG).
  • Patients with active stomach ulcers or bleeding.

Conditional Use Requirements

Official labeling requires individuals with certain medical histories to consult a health professional before use. These include patients with:

  • Cardiovascular Conditions: High blood pressure, heart disease, or a history of stroke.
  • Organ Impairment: Liver cirrhosis or kidney disease.
  • Metabolic/Other Disorders: Asthma, diabetes, thyroid disease, glaucoma, or trouble urinating due to an enlarged prostate gland.

What should I know about interactions with other medicines?

Modafen Grip's interaction profile is defined by the concurrent effects of its Ibuprofen (NSAID) and Phenylephrine (decongestant) components. Regulatory guidance focuses on avoiding combinations that lead to excessive sympathetic stimulation or increased bleeding risk, as stated in official product labels.

Contraindicated Combinations and Timing Rules

  • Co-administration with Monoamine Oxidase Inhibitors (MAOIs) is strictly prohibited due to the risk of severe pharmacodynamic reinforcement from the Phenylephrine component. Use of Modafen Grip is not allowed for a minimum of 14 days after stopping MAOI therapy.
  • The combination is also contraindicated with other sympathomimetic amines or nasal decongestants to prevent additive effects.

Clinically Significant Interaction Classes

  • Increased Risk of Bleeding: The Ibuprofen component enhances the effect of Anticoagulants (e.g., Warfarin). The risk of gastrointestinal bleeding is increased when co-ingested with Alcohol (Ethanol) or other NSAIDs.
  • Reduced Efficacy: Ibuprofen may reduce the therapeutic blood pressure-lowering effect of certain Antihypertensives (e.g., ACE inhibitors, Diuretics) and may interfere with the anti-platelet benefit of low-dose Aspirin.
  • Exposure Modification: Co-administration with Acetaminophen is documented to increase the serum concentration of the Phenylephrine component.
  • Population Note: The risk of serious gastrointestinal bleeding associated with Ibuprofen is noted as being higher for elderly patients (aged 60 or older), especially when co-administered with other interacting substances.

Mechanism of Action

How Modafen Grip Works

Modafen Grip acts by engaging two distinct mechanistic domains: enzyme-mediated inflammatory modulation and receptor-mediated vascular constriction.


Enzyme-Mediated Modulation of Inflammatory Mediators

This domain focuses on the inhibition of Cyclooxygenase (COX) enzymes, the primary biological targets responsible for converting fatty acids into prostaglandins. These lipid mediators are involved in thermoregulatory and nociceptive signaling cascades. By suppressing their formation, the mechanism causes suppression of excessive signaling within the body's thermoregulatory and nociceptive pathways, which alters the dynamics of those pathways.


Receptor-Mediated Regulation of Vascular Tone

This domain involves the active component acting as an agonist on alpha-adrenergic receptors (alpha1), which are key components of the sympathetic nervous system pathways controlling blood vessel diameter. Activation of these receptors in the nasal and sinus lining initiates vasoconstriction (vessel narrowing). This action causes a reduction in localized blood flow in the mucosal vasculature, which alters the fluid dynamics and volume within the targeted mucous membranes.

Dosage and Administration Information

How to Use Modafen Grip

This section outlines the standardized usage patterns and dosing principles for the Modafen Grip combination product, which contains Ibuprofen 200 mg and Phenylephrine HCl 5 mg.


Administration Protocol

The administration of this dual-component medication is defined by specific guidelines regarding route, frequency, and maximum dosage. The approved route of administration is oral, with the medication supplied as a film-coated tablet.

The standard 24-hour period must not include more than 6 tablets in total, which constitutes the maximum daily dose. Adherence to this limit is a key procedural requirement.


Dosing Schedule and Contextual Use

Category Standard Principle
Unit Dose One (1) film-coated tablet.
Dosing Frequency Every 4 hours, taken as needed.
Duration Principle Intended for short-term use only, administered while symptoms persist.
Contextual Intake May be taken with food or milk if the individual experiences stomach discomfort.
Age Restriction Approved for use in adults and children 12 years of age and older.

The usage protocol establishes that one tablet is the single unit dose, and the dosing cycle is based on a 4-hour interval. The instructions restrict use to individuals 12 years of age and older, and administration should cease once the symptomatic period has ended, limiting the course duration. These parameters define the standardized framework for the medication's use.

Recent Clinical Evidence

Research evidence / Overview of studies for Modafen Grip

This section summarizes the structure of the clinical evidence for the Modafen Grip combination of ibuprofen and phenylephrine, drawing from key research (including Randomized Controlled Trials and systematic reviews) and regulatory findings. It is intended to research describe the available research, the outcomes that was observed in studies, and the aspects that remain uncertain, without offering clinical advice or making claims about personal outcomes.


Evidence for Use in Conditions Characterized by Fluctuating or Episodic Manifestations

Research for this combination product evaluated outcomes related to systemic or functional imbalance associated with acute viral illness, such as the common cold or flu. Studies explored outcomes related to physical discomfort with this combination, including general body aches, headache, and fever, as well as symptoms of nasal congestion.

Evidence includes Randomized Controlled Trials (RCTs) which examined patient populations experiencing periods of heightened symptom activity. Research describes a consistent pattern for the analgesic and fever-reducing component (ibuprofen), which was associated with changes in pain and temperature scores reported during the study period.

Focus on the Decongestant Evidence Component

Research examined the decongestant component, phenylephrine, in numerous studies. The findings describe patterns related to the evidence for the oral decongestant component, which may be heterogeneous or lacking consistency. Regulatory analyses, including those from the U.S. Food and Drug Administration (FDA), have identified uncertainty and inconsistency in the data regarding the efficacy of this ingredient for relieving common cold symptoms. This evidence highlights what is known — and what is still uncertain — about this specific component’s effect.

Uncertainty and Research Gaps

A synthesis of the available evidence points to several areas where certainty remains low. The primary research limitation is the continued inconsistency or uncertainty regarding the efficacy of the oral decongestant component, phenylephrine, for common cold symptoms. Comparative evidence is lacking to definitively establish the differential effect of the fixed combination versus using the pain and fever reliever alone. Furthermore, follow-up durations were limited to the acute phase of illness, meaning long-term effects remain to be fully characterized.

Key Studies & References

  1. U.S. Food and Drug Administration (FDA) Label for Ibuprofen and Phenylephrine Combination
  2. Ibuprofen Monograph/Regulatory Summary (DailyMed/FDA)
  3. Management of the common cold: a review of available treatments

Frequently Asked Questions (FAQ)

Common questions about Modafen Grip (FAQ)


Q: How quickly does Modafen Grip typically start working?

A: Official information indicates that this product is dosed every 4 hours, which provides a general sense of the expected duration of effects. While the exact time to onset is not specified, clinical data on similar ibuprofen combinations suggests that the time to maximum concentration (Tmax) is not expected to significantly alter the typical onset of action for this class of medicine.


Q: Is it possible to have an allergic reaction to Modafen Grip?

A: Yes, regulatory documents contain an allergy alert for this medication. The alert specifically notes that the ibuprofen component may cause a severe allergic reaction, especially in individuals who have a known allergy to aspirin. Signs of a severe allergic reaction can include hives, facial swelling, asthma symptoms (wheezing), or shock.


Q: What are the most commonly reported side effects?

A: According to the official product information, commonly reported side effects are related to mild gastrointestinal discomfort, such as heartburn, nausea, or stomach pain. Other common effects related to the nervous system include dizziness, feeling nervous, and sleep problems, often referred to as insomnia.


Q: What should I do if I think I have taken too much Modafen Grip?

A: Official documentation states that if an accidental overdose is suspected, contacting a Poison Control Center or seeking emergency medical help is mandated. This is advised right away, even if no obvious symptoms are present.


Q: What is the duration of the effects of Modafen Grip?

A: The duration of effect is framed by the official dosing directions. The product label specifies that one dose may be administered every 4 hours, which indicates the typical time frame for when symptomatic relief is expected to be maintained.


Q: What is the official advice about when to stop taking Modafen Grip?

A: Official labeling contains instructions for stopping use, which include contacting a health professional if pain or nasal congestion lasts for more than 7 days, or if fever lasts for more than 3 days. This information guides users on when to seek professional re-evaluation of symptoms.


Q: Is it necessary to take Modafen Grip with food?

A: Official labeling states that the medication is commonly administered with food or milk when stomach upset is a concern. The label does not mandate taking the product with food, indicating it may be taken independently of meals.


Q: Can someone who has liver problems use Modafen Grip?

A: Official guidelines state that individuals with liver disease must consult a healthcare professional prior to use. This oversight is specified because the dosage may require professional adjustment for conditions affecting the liver.


Q: Can I use Modafen Grip if I have asthma?

A: Official product information lists asthma as a medical condition for which consultation with a health professional is specified prior to use. This professional oversight relates to the product's safety constraints.


Q: Can Modafen Grip make you feel drowsy or sleepy?

A: The product label lists dizziness as a potential side effect, which can affect alertness. Although this specific formulation is often described as non-drowsy, dizziness and sleep problems (insomnia) are noted as common side effects.


Q: Do I need a prescription to get Modafen Grip?

A: The product is classified as a Human Over-the-Counter (OTC) drug label in most markets. This classification means that a doctor's prescription is typically not required for its purchase.


Q: Is Modafen Grip commonly used for headaches?

A: Yes, official uses include the temporary relief of symptoms associated with the common cold or flu, including headache. The ibuprofen component serves as a pain reliever.


Q: Can Modafen Grip be taken if I am already taking an anti-anxiety medicine?

A: The phenylephrine component may interact with medications that affect the central nervous system. A review of all current medications, including anti-anxiety medicine, is part of the professional oversight specified before use.


Q: What happens if I forget to take a dose of Modafen Grip?

A: Official advice provides guidance for handling missed doses, generally suggesting that if it is almost time for the next dose, the user should avoid taking the missed dose to prevent exceeding recommended amounts. The product should then continue to be used at the next scheduled time.


Q: Is there any research evidence on how well Modafen Grip works?

A: Research evidence describes a consistent pattern of efficacy for the ibuprofen component in relieving pain and fever. However, U.S. regulatory analyses have identified uncertainty and inconsistency regarding the effectiveness of the oral decongestant component, phenylephrine, for common cold symptoms.


Q: Is Modafen Grip safe to use if I have diabetes?

A: Official labeling lists diabetes as a condition for which consultation with a health professional is specified prior to use. This professional oversight is required to ensure suitability for the individual.


Q: Does Modafen Grip contain aspirin?

A: The active ingredients are Ibuprofen and Phenylephrine HCl. However, the official allergy alert warns that ibuprofen may cause a severe allergic reaction, especially in individuals who are allergic to aspirin.


Q: Is it true that Modafen Grip can cause stomach upset?

A: Yes, official documentation lists mild gastrointestinal discomfort, such as stomach pain and heartburn, as common side effects. Furthermore, due to the ibuprofen component, a mandated warning regarding the risk of severe stomach bleeding is included.


Q: Can taking Modafen Grip affect my ability to drive?

A: Official labeling advises users to be careful when operating machinery or driving a motor vehicle. This is because the medicine may cause side effects, such as dizziness, that could potentially affect alertness and concentration.


Q: Does Modafen Grip have a long-term risk if used short-term?

A: The risks of serious events, such as severe stomach bleeding, are officially stated to be higher when the product is used at higher doses or for longer durations than directed. No long-term risks are explicitly stated for use exactly as directed (short-term) in the core safety warnings.


Q: What ingredients are in Modafen Grip?

A: The product contains two active ingredients: Ibuprofen and Phenylephrine HCl. Official documentation also provides a list of inactive ingredients, which may include components like lactose monohydrate, titanium dioxide, and talc.


Q: Can Modafen Grip cause difficulty sleeping?

A: Yes, difficulty sleeping is listed among the common side effects. Official reports of adverse events specifically categorize this effect as insomnia.


Q: Does the medicine come in a liquid or chewable form?

A: The core product described in official regulatory labeling is a film-coated tablet. Information regarding the availability of other dosage forms, such as liquid or chewable forms, is not found in the main label for this specific product.


Q: Are there any known interactions with common foods or drinks, like caffeine?

A: Phenylephrine, the decongestant component, may interact with common substances like caffeine. Since both components can potentially increase blood pressure and heart rate, combining them could possibly enhance these stimulant effects.


Q: Is it normal to feel a bit restless after taking Modafen Grip?

A: Official information lists nervousness as a common side effect of this product. The decongestant component, phenylephrine, may cause a feeling of restlessness or excitement, particularly in some users.


Q: Are there any specific organs that Modafen Grip could potentially affect?

A: Regulatory warnings and conditional use requirements indicate potential effects on the gastrointestinal system, the cardiovascular system (heart), the kidneys, and the liver. These are the primary organ systems of safety concern noted in the official documentation.


Q: Does Modafen Grip interact with blood thinners?

A: Yes, official labeling states that the ibuprofen component enhances the effect of anticoagulant medications (commonly referred to as blood thinners), such as Warfarin. This combination increases the risk of bleeding.


Q: Can I take Modafen Grip if I am lactose intolerant?

A: The list of inactive ingredients for this product formulation includes lactose monohydrate. Individuals with lactose intolerance should be aware of this component.


Q: Are there specific times of day that are better for taking Modafen Grip?

A: The directions advise taking the product every 4 hours 'while symptoms persist.' Due to the common side effect of sleep problems (insomnia), administration of the product close to bedtime may be avoided.


Q: What type of fever is Modafen Grip intended to treat?

A: The product's official uses state that it is indicated for the temporary relief of fever specifically associated with the common cold or flu.


Q: Does Modafen Grip make you feel better or just manage symptoms?

A: The official uses state that the product is intended for the temporary relief of symptoms, which includes fever, headache, minor body aches, and nasal congestion. It manages the symptoms associated with the illness rather than treating the underlying cause.


Q: Are there any officially documented rare side effects of Modafen Grip?

A: Yes, official documentation highlights serious adverse reactions that are rare but significant. These include life-threatening cardiovascular events, such as heart attack and stroke, as well as severe gastrointestinal events, such as stomach bleeding and perforation.

How should Modafen Grip be stored and disposed of?

Storage Requirements

Modafen Grip must be stored at controlled room temperature, specifically between 20^circC and 25^circC (68^circF and 77^circF). Storage environments must avoid excessive heat above 40^circC and be protected from excess moisture. The medication must remain in its tightly closed original container or sealed blister, and should not be used if the protective packaging is broken.

Child Safety

It is mandatory to store the medicine out of the sight and reach of children to prevent accidental ingestion.

Disposal Instructions

Unused or expired Modafen Grip should not be flushed down the toilet or disposed of in regular wastewater, as it is not on the official flush list. The preferred method for disposal is through a drug take-back program. If a take-back program is unavailable, the product may be mixed with an unappealing substance (like dirt or coffee grounds), sealed in a bag, and then placed in household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Modafen Grip found in:

A-Z Index: